RPRX Dividend History & Yield
Royalty Pharma plc · NasdaqGS
Upcoming dividend payments
| Ex-date | Pay date | Per share | Per 100 shares | Status |
|---|---|---|---|---|
| Fri, Nov 13, 2026 (in 65 days) | Dec 9, 2026 | $0.235 | $23.50 | Estimated |
| Fri, Feb 12, 2027 (in 156 days) | Mar 10, 2027 | $0.235 | $23.50 | Estimated |
| Fri, May 14, 2027 (in 247 days) | Jun 9, 2027 | $0.235 | $23.50 | Estimated |
| Fri, Aug 13, 2027 (in 338 days) | Sep 8, 2027 | $0.235 | $23.50 | Estimated |
Estimated dates and amounts are projected from RPRX's recent payment pattern and will be replaced by declared figures when the company announces them. Total over the next 12 months: about $0.94 per share.
Dividend payment history
Last 25 payments per share. RegularSpecial
Annual dividends per share
How much RPRX do you need for monthly income?
| Target income | Shares needed | Capital at today's price | Per year |
|---|---|---|---|
| $100 / month | 1,277 | $77,349 | $1,200 |
| $500 / month | 6,383 | $386,745 | $6,000 |
| $1,000 / month | 12,766 | $773,489 | $12,000 |
Based on the forward yield of 1.55%. $10,000 in RPRX would currently pay about $155 a year ($13 a month on average). Model reinvestment and growth →
RPRX dividend history
| Ex-date | Pay date | Amount | Change |
|---|---|---|---|
| Aug 14, 2026 | Sep 10, 2026 | $0.235 | +0.0% |
| May 15, 2026 | Jun 10, 2026 | $0.235 | +0.0% |
| Feb 20, 2026 | Mar 10, 2026 | $0.235 | +6.8% |
| Nov 14, 2025 | Dec 10, 2025 | $0.22 | +0.0% |
| Aug 15, 2025 | Sep 10, 2025 | $0.22 | +0.0% |
| May 16, 2025 | Jun 10, 2025 | $0.22 | +0.0% |
| Feb 21, 2025 | Mar 10, 2025 | $0.22 | +4.8% |
| Nov 15, 2024 | Dec 10, 2024 | $0.21 | +0.0% |
| Aug 16, 2024 | Sep 13, 2024 | $0.21 | +0.0% |
| May 16, 2024 | Jun 14, 2024 | $0.21 | +0.0% |
| Feb 15, 2024 | Mar 15, 2024 | $0.21 | +5.0% |
| Nov 16, 2023 | Dec 15, 2023 | $0.20 | +0.0% |
| Aug 17, 2023 | Sep 15, 2023 | $0.20 | +0.0% |
| May 18, 2023 | Jun 15, 2023 | $0.20 | +0.0% |
| Feb 15, 2023 | Mar 15, 2023 | $0.20 | +5.3% |
| Nov 17, 2022 | Dec 15, 2022 | $0.19 | +0.0% |
| Aug 18, 2022 | Sep 15, 2022 | $0.19 | +0.0% |
| May 19, 2022 | Jun 15, 2022 | $0.19 | +0.0% |
| Feb 17, 2022 | Mar 15, 2022 | $0.19 | +11.8% |
| Nov 18, 2021 | Dec 15, 2021 | $0.17 | +0.0% |
| Aug 19, 2021 | Sep 15, 2021 | $0.17 | +0.0% |
| May 19, 2021 | Jun 15, 2021 | $0.17 | +0.0% |
| Feb 18, 2021 | Mar 15, 2021 | $0.17 | +13.3% |
| Nov 19, 2020 | Dec 15, 2020 | $0.15 | +0.0% |
| Sep 14, 2020 | Sep 30, 2020 | $0.15 | — |
RPRX dividend increases & cuts
Market-wide changes →| Ex-date | Change | Old | New | Status |
|---|---|---|---|---|
| Feb 20, 2026 | Raised 6.8% | $0.22 | $0.235 | Paid |
Detected from the regular payment stream; supplemental and special dividends are excluded. Pro members get an email the morning a holding raises or cuts.
Payout risk check
RPRX scores 0/100 on our yield-trap heuristic (low risk).
No warning flags: the payout ratio, yield level, 5-year cut history and price trend all look ordinary.
This is a rule-based screen computed from public data, not a rating or a recommendation. Read our guide to yield traps for what the signals mean.
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Sector: Healthcare. Industry: Biotechnology. First dividend on our records: Sep 14, 2020. 25 payments tracked. Data last refreshed Sep 9, 2026. Spotted a mistake? Report it and we'll fix it.
RPRX dividend FAQ
When is RPRX's next ex-dividend date?
RPRX's next ex-dividend date is Nov 13, 2026 (in 65 days, estimated from its quarterly schedule). You must own the shares before that date to receive the payment of about $0.235 per share, expected on Dec 9, 2026.
How often does RPRX pay dividends?
RPRX pays dividends every quarter, 4 times a year. The most recent payment was $0.235 per share with an ex-date of Aug 14, 2026.
What is RPRX's dividend yield?
RPRX's trailing 12-month dividend yield is 1.53%, based on $0.925 per share paid over the last year and a share price of $60.59. The forward yield, using the indicated annual rate of $0.94 per share, is 1.55%.
How much does RPRX pay per share?
RPRX pays about $0.235 per share each quarter, which works out to roughly $0.94 per share a year. 100 shares would collect about $94.00 a year.
Has RPRX grown or cut its dividend?
RPRX has raised its annual dividend for 5 consecutive years. Over the last 3 years the regular payout changed +5.4% a year. There has been no cut to a regular payment in the last 5 years.
How many shares of RPRX do I need to earn $100 a month?
At the current forward yield of 1.55%, you would need about 1,277 shares of RPRX (roughly $77,349 invested at today's price) to collect $1,200 a year, or $100 a month on average, before taxes. Payments arrive every quarter, so the monthly figure is an average.
Similar dividend stocks
| Symbol | Type | Price | TTM yield | Annual / share | Frequency | Next ex-date | Trend |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly and Company | Stock | $1,123.91 | 0.60% | $6.92 | Quarterly | Nov 13 Est. | |
| JNJJohnson & Johnson | Stock | $269.12 | 1.96% | $5.36 | Quarterly | Nov 24 Est. | |
| ABBVAbbVie Inc. | Stock | $248.78 | 2.75% | $6.92 | Quarterly | Oct 14 Est. | |
| MRKMerck & Co., Inc. | Stock | $148.46 | 2.26% | $3.40 | Quarterly | Sep 15 Declared | |
| UNHUnitedHealth Group Incorporated | Stock | $400.84 | 2.23% | $9.28 | Quarterly | Sep 14 Declared | |
| NVSNovartis AG | Stock | $137.70 | 3.47% | $4.773 | Annual | Mar 11 Est. | |
| AZNAstraZeneca PLC | Stock | $160.04 | 1.35% | $4.306 | Semi-annual | Feb 18 Est. | |
| TMOThermo Fisher Scientific Inc. | Stock | $603.02 | 0.30% | $1.88 | Quarterly | Sep 15 Declared |